1-3 of 3
P. Mahendra
Close
Sort by
Journal Articles

Allogeneic Stem Cell Transplantation Using a Reduced Intensity Conditioning (RIC) Regimen Has the Capacity To Produce Durable Remissions and Long Term Disease-Free Survival in Patients with High Risk Acute Myeloid Leukemia (AML).

S. Tauro, S. Mackinnon, K. Peggs, G. Begum, P. Mahendra, G. Cook, J. Marsh, D. Milligan, A. Goldstone, A. Hunter, A. Khwaja, R. Chopra, T. Littlewood, A. Peniket, A. Parker, G. Jackson, G. Hale, M. Cook, N. Russell, C. Craddock
Journal: Blood
Blood (2005) 106 (11): 1141.
https://doi.org/10.1182/blood.V106.11.1141.1141
Published: 2005
Journal Articles

Serial Analysis of Whole Blood Cell and CD3 + T-Lymphocyte Chimerism Following Allogeneic Stem Cell Transplantation with Alemtuzumab Containing Reduced-Intensity-Conditioning (RIC).

S. Tauro, R. Lovell, G. Begum, D. J. McMullan, M. J. Griffiths, F. J. Clark, M. A. Cook, P. Mahendra, D. W. Milligan, C. F. Craddock
Journal: Blood
Blood (2005) 106 (11): 1776.
https://doi.org/10.1182/blood.V106.11.1776.1776
Published: 2005
Journal Articles

Impact of In Vivo T-Cell Depletion on Outcome Following Reduced Intensity Transplantation for Hodgkin Lymphoma: Comparison between 2 Prospective Studies.

K. S. Peggs, A. Sureda, A. Hunter, M. D. Caballero, J. Cavet, A. Urbano-Ispizua, A. Parker, J. M. Ribera, P. Mahendra, M. A. Canales, D. Milligan, J. C. Hernandez-Boluda, E. C. Morris, I. Alvarez, A. H. Goldstone, D. C. Linch, J. Sierra, S. Mackinnon
Journal: Blood
Blood (2004) 104 (11): 807.
https://doi.org/10.1182/blood.V104.11.807.807
Published: 2004